Vivo Opportunity, LLC, 10% Owner at InMed Pharmaceuticals Inc. (INM), bought 20,546 shares at $1.55 ($32K) on 2026-07-14, disclosed to the SEC on 2026-07-16.
Open-market purchase of $32k INM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.55 | 493 | $764 | 2.4% |
| 2 | $1.55 | 4,882 | $8K | 23.8% |
| 3 | $1.55 | 1,389 | $2K | 6.8% |
| 4 | $1.55 | 13,761 | $21K | 67.0% |
| 5 | $1.55 | 2 | $3 | 0.0% |
| 6 | $1.55 | 19 |
| $29 |
| 0.1% |
| Total | $1.55 avg | 20,546 | $32K | 100% |
| Filing → |
| SLNO | SELL | 2024-08-29 | $49.2M | — | Filing → |
| TERN | SELL | 2024-04-03 | $4.9M | — | Filing → |
| TERN | BUY | 2022-09-08 | $2.2M | — | Filing → |